All news

BaroPharm sinks 18.7% in KOSDAQ debut as foreigners resume selling Korean stocks

AJP (Aju Press) · · AI-summarised by FinFlash

Drugmaker BaroPharm fell 18.7% on its first day of KOSDAQ trading to 13,340 won, well below its 16,400 won offer price. Elsewhere in Seoul, foreign investors net sold 88.9 billion won of shares by mid-morning after their first net purchase in eight sessions on Tuesday, while individuals bought 44.8 billion won. Jusung Engineering jumped 9.7% to 167,000 won and Samsung SDI rose 1.5%.

So What?

A weak debut points to fragile IPO appetite in Korea; renewed foreign selling remains the key risk for the Kospi's recovery.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.